1-46189457-C-G

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PS3PM2PP5_Moderate

The NM_017739.4(POMGNT1):​c.1895+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). ClinVar reports functional evidence for this variant: "SCV003325252: Studies have shown that disruption of this splice site results in activation of a cryptic splice site and introduces a new termination codon (PMID:22554691, 28424332). RNA analysis indicates that disruption of this splice site induces altered splicing and likely disrupts the C-terminus of the protein.".

Frequency

Genomes: not found (cov: 32)

Consequence

POMGNT1
NM_017739.4 splice_donor, intron

Scores

2
3
2
Splicing: ADA: 0.9945
2

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.53

Publications

4 publications found
Variant links:
Genes affected
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
TSPAN1 (HGNC:20657): (tetraspanin 1) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017739.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PS3
PS3 evidence extracted from ClinVar submissions: SCV003325252: Studies have shown that disruption of this splice site results in activation of a cryptic splice site and introduces a new termination codon (PMID: 22554691, 28424332). RNA analysis indicates that disruption of this splice site induces altered splicing and likely disrupts the C-terminus of the protein.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-46189457-C-G is Pathogenic according to our data. Variant chr1-46189457-C-G is described in ClinVar as Pathogenic. ClinVar VariationId is 557018.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017739.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
NM_017739.4
MANE Select
c.1895+1G>C
splice_donor intron
N/ANP_060209.4Q8WZA1-1
POMGNT1
NM_001243766.2
c.1869+27G>C
intron
N/ANP_001230695.2Q8WZA1-2
POMGNT1
NM_001410783.1
c.1895+1G>C
splice_donor intron
N/ANP_001397712.1A0A8I5KNB7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMGNT1
ENST00000371984.8
TSL:1 MANE Select
c.1895+1G>C
splice_donor intron
N/AENSP00000361052.3Q8WZA1-1
POMGNT1
ENST00000371992.1
TSL:2
c.1869+27G>C
intron
N/AENSP00000361060.1Q8WZA1-2
POMGNT1
ENST00000692369.1
c.1895+1G>C
splice_donor intron
N/AENSP00000508453.1A0A8I5KNB7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 (1)
1
-
-
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Benign
-0.18
CADD
Pathogenic
33
DANN
Uncertain
0.99
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
PhyloP100
7.5
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
0.94
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.21
Position offset: 27
DS_DL_spliceai
0.94
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs386834024;
hg19: chr1-46655129;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.